News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alexion Pharmaceuticals Inc. (ALXN) CEO Racks Up $30 Million Salary In 2013


4/24/2014 7:03:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The CEO of Alexion, the Cheshire-based pharmaceutical company that makes the most expensive drug in the world, received $30.15 million in compensation last year, according to a federal filing Wednesday. Alexion, which developed a biologic drug from CEO Dr. Leonard Bell's Yale research, only has one product so far: Soliris. The drug treats ultra-rare diseases and generally insurers pay more than $400,000 each year for one patient. Patients need it for the rest of their lives.

Help employers find you! Check out all the jobs and post your resume.

Read at Courant

comments powered by Disqus
Courant
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES